Trial Profile
Aliskiren/hydrochlorothiazide in patients with aliskiren-refractory hypertension
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 05 Nov 2010
Price :
$35
*
At a glance
- Drugs Aliskiren/hydrochlorothiazide (Primary) ; Aliskiren
- Indications Hypertension
- Focus Therapeutic Use
- 05 Nov 2010 New trial record.
- 01 Jan 2008 Primary endpoint 'Seated-blood-pressure' has been met.